Zachary N Warnken

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Topics

Attention Deficit Hyperactivity Disorder

Oxide Nanoparticles

Hyaluronic Acid

Top Venues

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Samiullah Khan, Muhammad Usman Minhas, Muhammad Tahir Aqeel, Ihsan Shah, Shahzeb Khan, Mohsin Kazi, Zachary N Warnken
RETRACTED: Khan et al. Poly (N-vinylcaprolactam-grafted-sodium alginate) Based Injectable pH/Thermo Responsive In Situ Forming Depot Hydrogels for Prolonged Controlled Anticancer Drug Delivery; In Vitro, In Vivo Characterization and Toxicity Evaluation. Pharmaceutics 2022, 14 , 1050. Pharmaceutics 16 (1) (2024)
Samiullah Khan, Muhammad Usman Minhas, Muhammad Tahir Aqeel, Ihsan Shah, Shahzeb Khan, Mohsin Kazi, Zachary N Warnken
RETRACTED: Khan et al. Poly (N-vinylcaprolactam-grafted-sodium alginate) Based Injectable pH/Thermo Responsive In Situ Forming Depot Hydrogels for Prolonged Controlled Anticancer Drug Delivery; In Vitro, In Vivo Characterization and Toxicity Evaluation. Pharmaceutics 2022, 14 , 1050. Pharmaceutics 16 (1) (2024)
Samiullah Khan, Muhammad Usman Minhas, Muhammad Tahir Aqeel, Ihsan Shah, Shahzeb Khan, Mohsin Kazi, Zachary N Warnken
RETRACTED: Khan et al. Poly (N-vinylcaprolactam-grafted-sodium alginate) Based Injectable pH/Thermo Responsive In Situ Forming Depot Hydrogels for Prolonged Controlled Anticancer Drug Delivery; In Vitro, In Vivo Characterization and Toxicity Evaluation. Pharmaceutics 2022, 14 , 1050. Pharmaceutics 16 (1) (2024)
Samiullah Khan, Muhammad Usman Minhas, Muhammad Tahir Aqeel, Ihsan Shah, Shahzeb Khan, Mohsin Kazi, Zachary N Warnken
Poly (N-Vinylcaprolactam-Grafted-Sodium Alginate) Based Injectable pH/Thermo Responsive In Situ Forming Depot Hydrogels for Prolonged Controlled Anticancer Drug Delivery; In Vitro, In Vivo Characterization and Toxicity Evaluation. Pharmaceutics 14 (5) (2022)
Miguel O Jara, Zachary N Warnken, Sawittree Sahakijpijarn, Rishi Thakkar, Vineet R Kulkarni, Dale J Christensen, John J Koleng, Robert O Williams
Oral Delivery of Niclosamide as an Amorphous Solid Dispersion That Generates Amorphous Nanoparticles during Dissolution. Pharmaceutics 14 (12) (2022)
Miguel O Jara, Zachary N Warnken, Sawittree Sahakijpijarn, Rishi Thakkar, Vineet R Kulkarni, Dale J Christensen, John J Koleng, Robert O Williams
Oral Delivery of Niclosamide as an Amorphous Solid Dispersion That Generates Amorphous Nanoparticles during Dissolution. Pharmaceutics 14 (12) (2022)
Miguel O Jara, Zachary N Warnken, Sawittree Sahakijpijarn, Rishi Thakkar, Vineet R Kulkarni, Dale J Christensen, John J Koleng, Robert O Williams
Oral Delivery of Niclosamide as an Amorphous Solid Dispersion That Generates Amorphous Nanoparticles during Dissolution. Pharmaceutics 14 (12) (2022)
Miguel O Jara, Zachary N Warnken, Sawittree Sahakijpijarn, Rishi Thakkar, Vineet R Kulkarni, Dale J Christensen, John J Koleng, Robert O Williams
Oral Delivery of Niclosamide as an Amorphous Solid Dispersion That Generates Amorphous Nanoparticles during Dissolution. Pharmaceutics 14 (12) (2022)
Miguel O Jara, Zachary N Warnken, Robert O Williams
Amorphous Solid Dispersions and the Contribution of Nanoparticles to In Vitro Dissolution and In Vivo Testing: Niclosamide as a Case Study. Pharmaceutics 13 (1) (2021)
Haiyue Xu, Riyad F Alzhrani, Zachary N Warnken, Sachin G Thakkar, Mingtao Zeng, Hugh D C Smyth, Robert O Williams, Zhengrong Cui
Immunogenicity of Antigen Adjuvanted with AS04 and Its Deposition in the Upper Respiratory Tract after Intranasal Administration. Molecular pharmaceutics 17 (9) (2020)
Yajie Zhang, BreAnne MacKenzie, John J Koleng, Esther Maier, Zachary N Warnken, Robert O Williams
Development of an Excipient-Free Peptide Dry Powder Inhalation for the Treatment of Pulmonary Fibrosis. Molecular pharmaceutics 17 (2) (2020)
Hiroyuki Takabe, Zachary N Warnken, Yajie Zhang, Daniel A Davis, Hugh D C Smyth, John G Kuhn, Steve Weitman, Robert O Williams Iii
A Repurposed Drug for Brain Cancer: Enhanced Atovaquone Amorphous Solid Dispersion by Combining a Spontaneously Emulsifying Component with a Polymer Carrier. Pharmaceutics 10 (2) (2018)
Zachary N Warnken, Hugh D C Smyth, Daniel A Davis, Steve Weitman, John G Kuhn, Robert O Williams
Personalized Medicine in Nasal Delivery: The Use of Patient-Specific Administration Parameters To Improve Nasal Drug Targeting Using 3D-Printed Nasal Replica Casts. Molecular pharmaceutics 15 (4) (2018)